Ticker Symbol: CNTX

Context Therapeutics Inc

$4.90 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001842952

Company Profile

context therapeutics is dedicated to discovering, acquiring, and developing novel compounds to treat hormone responsive cancers. our lead program is apristor (onapristone xr), an investigational drug for progesterone receptor positive (pr+) breast cancer. up to 70% of breast cancers express progesterone receptor (pr). if your cancer is pr+, apristor could be an option for you.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: 3675 Market Street

Website: http://www.contexttherapeutics.com/

CEO: N/A

Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $1.39

Change: -$0.02 ( -1.42%)

Days Range: $1.36 - $1.45

Beta: 1.09

52wk. High: $1.69

52wk. Low: $0.47

Ytd. Change 114.94%

50 Day Moving Average: $1.14

200 Day Moving Average: $1.03

Shares Outstanding: 15966053

Valuation

Market Cap: 2.2B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A